Table 3 Characteristics of children receiving ART (n = 54)
From: Barriers to the care of HIV-infected children in rural Zambia: a cross-sectional analysis
| Â | At clinic enrollment | At ART initiationa | At study enrollment |
|---|---|---|---|
Median age (yrs) (IQR) | 3.6 (1.5, 7.7) | 3.8 (2.0, 8.0) | 4.5 (2.7, 8.6) |
Median WAZ (IQR) b | -2.7 (-3.5, -1.5) | -2.5 (-3.9, -1.8) | -2.4 (-3.2, -1.5) |
   WAZ <-2 | 27 (61.4) | 28 (70.0) | 26 (60.5) |
   WAZ ≥-2 | 17 (38.6) | 12 (30.0) | 17 (39.5) |
Median CD4 + T cell % (IQR) | 14.0 (9.2, 19.0) | 12.4 (9.2, 18.6) | 28.6 (23.5, 36.1) |
Median CD4 + T cell count (IQR) | 505 (281, 985) | 368 (219, 559) | 973 (466, 1522) |
   Severe immunodeficiencyc | 16 (50) | 24 (63) | 2 (5) |
Median total lymphocyte count (IQR) | 3194 (1948, 5351) | 2747 (1634, 5351) | 3372 (1862, 5276) |
Median hemoglobin (IQR) | 10.6 (10.0, 11.7) | 10.8 (10.0, 12.0) | 11.9 (10.6, 12.3) |
   Hemoglobin <8 gm/dL | 1 (2.0) | 0 (0) | 4 (8.9) |
   Hemoglobin ≥8 gm/dL | 49 (98.0) | 36 (100.0) | 41 (91.1) |
WHO stage | Â | Â | Â |
   1 | 2 (5.1) | 2 (7.1) | 6 (17.7) |
   2 | 9 (23.1) | 1 (3.6) | 6 (17.7) |
   3 | 22 (56.4) | 20 (71.4) | 20 (58.8) |
   4 | 6 (15.4) | 5 (17.9) | 2 (5.9) |
ART regimen | Â | Â | Â |
   AZT/3TC/EFV | --- | 12 (26.1) | 11 (42.3) |
   AZT/3TC/NVP | --- | 11 (23.9) | 7 (26.9) |
   d4T/3TC/EFV | --- | 5 (10.8) | 2 (7.7) |
   d4T/3TC/NVP | --- | 18 (39.1) | 6 (23.1) |